<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Plant Biotechnology Persa</title>
<title_fa>عنوان نشریه</title_fa>
<short_title>pbp</short_title>
<subject>Literature &amp; Humanities</subject>
<web_url>http://pbp.medilam.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2676-7414</journal_id_issn>
<journal_id_issn_online>2676-7414</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/pbp</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1402</year>
	<month>9</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Evaluation of QTc and Tp-e changes in Rheumatoid Arthritis and Ankylosing Spondylitis Patients Treated with Biological Drugs</title>
	<subject_fa></subject_fa>
	<subject>Herbal Drugs</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;span style=&quot;font-family:Tahoma;&quot;&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span sans-serif=&quot;&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Background: &lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Tumor necrosis factor-&amp;alpha; (TNF-&amp;alpha;) antagonists bring about significant improvement in chronic inflammatory diseases such as rheumatoid arthritis (RA) and spondyloarthritis (SpA), but they may have negative myocardial effects&lt;b&gt;. &lt;/b&gt;This study aimed to evaluate the changes in QTc and Tp-e in RA and AS patients treated with biological drugs.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span sans-serif=&quot;&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Methods:&lt;/span&gt;&lt;/b&gt; &lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;This cross-sectional study included all eligible patients referred to Imam Khomeini Hospital, Urmia, Iran from March 2021 to February 2022 and were randomly divided into two groups (anti-TNF group treated with methotrexate, rituximab, etanercept, adalimumab, infliximab and control group treated with methotrexate). Electrocardiographs (ECG) were performed on all participants at baseline and 6 months after initiation of treatment, and the QT, QTd, and TpTe were calculated with standard procedures.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span sans-serif=&quot;&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Result: &lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Of 128 patients with RA or AS, 64 patients were included in the anti-TNF group and control group, separately.&amp;nbsp; There was predominance of male gender: 69 (53.9%) vs. 59 (46.1%) among all patients with mean age of 47.77 years. After 6 months, the anti-TNF group already displayed a shorter mean QT and QTC than control group (418.7&amp;plusmn;15.6. ms vs. 414.0&amp;plusmn;17.5 ms, p =0.03; 461.7&amp;plusmn;25. 0 vs. 448.3&amp;plusmn;11.2, p=0.2), longer mean TpTE than control group (71.4&amp;plusmn;6.7 vs. 70.4&amp;plusmn;7.4, p=0.6). Post treatment increases in the QT were detected exclusively in the subgroup of patients being treated with Infliximab, Etanercept, Adalimumab, Rituximab for RA, which all were significant (P= 0.002, 0.001, 0.001, 0.001, respectively). In contrast, post treatment changes in the QTd and QTdc indices were not outstanding and statistically significant.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:150%&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;span sans-serif=&quot;&quot;&gt;&lt;b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Conclusion: &amp;nbsp;&lt;/span&gt;&lt;/b&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;This study demonstrated that Tp-e interval and Tp-e/QT ratio were elevated in RA and AS patients. As previously reported, anti-TNF drugs induce a substantial rise in QT and QTc levels, which can pose considerable risks to patients due to their asymptomatic presentation. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>,Tp-e interval,Tp-e/QT ratio,Rheumatoid arthritis Ankylosing spondylitis</keyword>
	<start_page>39</start_page>
	<end_page>47</end_page>
	<web_url>http://pbp.medilam.ac.ir/browse.php?a_code=A-10-641-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mir Amir</first_name>
	<middle_name></middle_name>
	<last_name>Aghdashi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>maaghdashi@umsu.ac.ir</email>
	<code>10031947532846005052</code>
	<orcid>10031947532846005052</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mojgan</first_name>
	<middle_name></middle_name>
	<last_name>Hajahmadi pourrafsanjan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hajahmadimojgan@gmail.com</email>
	<code>10031947532846005053</code>
	<orcid>10031947532846005053</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Cardilogy, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Tyyebe</first_name>
	<middle_name></middle_name>
	<last_name>Mokari</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Mokari.t@gmail.com</email>
	<code>10031947532846005054</code>
	<orcid>0009-0009-6382-0157 </orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
